To explore the impact of TLR4 inhibition in peritoneal fibrosis, male C57BL/6 mice were administered CG on alternate days, and treatment with daily TAK242 (PO) was initiated concurrently with CG. This evidence concerns the gene TLR4 and Peritoneal Fibrosis.